Peter Meintjes
Chief Executive Officer presso PACIFIC EDGE LIMITED
Patrimonio netto: 19 625 $ in data 31/03/2024
Profilo
Peter Meintjes is currently the Chief Executive Officer at Pacific Edge Ltd.
Prior to this, he was the Chief Executive Officer at Omixon Biocomputing Kft.
He received his doctorate degree from Auckland University in 2008 and also completed his undergraduate and graduate degrees at Auckland University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
PACIFIC EDGE LIMITED
0.05% | 25/10/2023 | 386 016 ( 0.05% ) | 19 625 $ | 31/03/2024 |
Posizioni attive di Peter Meintjes
Società | Posizione | Inizio |
---|---|---|
PACIFIC EDGE LIMITED | Chief Executive Officer | 17/01/2022 |
Precedenti posizioni note di Peter Meintjes
Società | Posizione | Fine |
---|---|---|
Omixon Biocomputing Kft
Omixon Biocomputing Kft Medical SpecialtiesHealth Technology Omixon Biocomputing Kft. provides diagnostics services. The firm specializes in data analysis, next-generation sequencing, software development, amplicon sequencing, NGS, HLA typing, HLA Assay and Software, Whole Gene Sequencing, Whole Exome Sequencing, HLA Genotyping kit, Omixon Academy, automation, epitope matching, and molecular diagnostics. The company was founded by Attila Berces and Márton Szoke in 2011 and is headquartered in Budapest, Hungary. | Chief Executive Officer | 20/04/2020 |
Formazione di Peter Meintjes
Auckland University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PACIFIC EDGE LIMITED | Health Technology |
Aziende private | 1 |
---|---|
Omixon Biocomputing Kft
Omixon Biocomputing Kft Medical SpecialtiesHealth Technology Omixon Biocomputing Kft. provides diagnostics services. The firm specializes in data analysis, next-generation sequencing, software development, amplicon sequencing, NGS, HLA typing, HLA Assay and Software, Whole Gene Sequencing, Whole Exome Sequencing, HLA Genotyping kit, Omixon Academy, automation, epitope matching, and molecular diagnostics. The company was founded by Attila Berces and Márton Szoke in 2011 and is headquartered in Budapest, Hungary. | Health Technology |
- Borsa valori
- Insiders
- Peter Meintjes